Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

2(40.0%)

N/A

1(20.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

Phase 1(2)

N/A(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT04287777Phase 3Completed

Safety and Efficacy of Mupirocin Gel in Children With Impetigo

Role: lead

NCT04452773Not ApplicableUnknown

Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers

Role: lead

NCT02593500Phase 1Completed

Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg

Role: lead

NCT02071589Phase 1Completed

Bioavailability Of A Single Dose Of Nifedipine Oral Solution Compared To Adalat Capsules In Healthy Female Volunteers

Role: lead

NCT01478425Phase 4Completed

Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen

Role: lead

All 5 trials loaded